Aspirin Reload Before Percutaneous Coronary Intervention: Reperfusion Indexes Evaluation.

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT01374698

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01374698
Other papers using this trial's data
  • Aspirin reload before elective percutaneous coronary intervention: impact on serum thromboxane b2 and myocardial reperfusion indexes Circulation. Cardiovascular interventions, 2014-08 DOI, PubMed 25074252

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01374698. Randomized; single masking; primary purpose treatment. Start 2011-01 (registry gives no type); primary completion 2011-09 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Aspirin Reload Before Percutaneous Coronary Intervention: Reperfusion Indexes Evaluation.
Condition
Coronary Arteriosclerosis
Intervention (Drug)
Aspirin
Lead sponsor
University of Roma La Sapienza (class: other)

Record details

Record id
cardio:ct-nct01374698
Content hash
b834249a6b8a870b3ab5d23da1ede0bb073ed13ec5257ebd48c6e202ec1a6d5f